BG Medicine (BGMD) Stock Analysis & Winston Score

BG Medicine is a small medical diagnostics company that develops blood tests used to help doctors diagnose and monitor heart disease. Its main product is a test that measures a protein called galectin-3, which is found in higher levels in patients with heart failure. Hospitals, clinics, and cardiologists are the primary customers for these diagnostic tools. The company earns revenue by selling its diagnostic tests and related reagents to healthcare providers, though it has struggled to generate enough sales to cover its costs. It operates primarily in the United States and is a very small player in the broader cardiac diagnostics market, which is dominated by much larger companies like Abbott and Roche. The deeply negative operating margin signals that the company spends far more than it earns, making its path to profitability and ability to compete against well-funded rivals the central risk investors should understand.